The Annals Visit the PharmaCE website!
home help contact us subscription past issues search current issue
 QUICK SEARCH:   [advanced]


     


The Annals of Pharmacotherapy: Vol. 31, No. 7, pp. 870-872.
© 1997 Harvey Whitney Books Company.
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mansoor, G.
Right arrow Articles by Aziz, K
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mansoor, G.
Right arrow Articles by Aziz, K


Research Articles

Delayed chronic diarrhea and weight loss possibly due to ticlopidine therapy

GA Mansoor and K Aziz

OBJECTIVE: To report a case of delayed-onset chronic diarrhea, anorexia, and weight loss possibly complicating the use of ticlopidine. CASE SUMMARY: A 48-year-old white man presented with unremitting diarrhea associated with anorexia and marked weight loss. His history was significant for transient ischemic attack, resistant hypertension, homocystinemia, and chronic renal insufficiency. The patient had tolerated ticlopidine therapy for 2 years without problems, and there had been no changes in his drug regimen for several months. No abnormality was found on detailed digestive system evaluation and all symptoms and signs promptly resolved after ticlopidine therapy was discontinued. DISCUSSION: The occurrence of diarrhea early during ticlopidine therapy should make the clinician consider the drug as the most likely cause. However, the appearance of chronic diarrhea, anorexia and weight loss years after a patient had tolerated the drug is less typical for ticlopidine. In such situations, if no other cause can be identified, cautious withdrawals of the drug should be considered. We believe that all the patient's symptoms reported here were likely due to ticlopidine. CONCLUSIONS: Clinicians should be aware that the gastrointestinal adverse effects of ticlopidine may surface years after therapy is begun. The cause of ticlopidine-induced diarrhea remains unknown.





homecopy help contact us subscription past issues search current issue
Copyright © 1997 by Harvey Whitney Books Company.